Invention Grant
US07749996B2 Heterotricyclic metalloprotease inhibitors 失效
异环金属蛋白酶抑制剂

Heterotricyclic metalloprotease inhibitors
Abstract:
The present invention relates generally to azatriocyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors.
Public/Granted literature
Information query
Patent Agency Ranking
0/0